- Home
- XTNT vs GDL Comparison
XTNT vs GDL Comparison
Compare XTNT & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- GDL
- Stock Information
- Founded
- XTNT N/A
- GDL 2006
- Country
- XTNT United States
- GDL United States
- Employees
- XTNT N/A
- GDL N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- GDL Investment Managers
- Sector
- XTNT Health Care
- GDL Finance
- Exchange
- XTNT Nasdaq
- GDL Nasdaq
- Market Cap
- XTNT 89.8M
- GDL 95.6M
- IPO Year
- XTNT N/A
- GDL N/A
- Fundamental
- Price
- XTNT $0.67
- GDL $8.55
- Analyst Decision
- XTNT
- GDL
- Analyst Count
- XTNT 0
- GDL 0
- Target Price
- XTNT N/A
- GDL N/A
- AVG Volume (30 Days)
- XTNT 104.0K
- GDL 11.2K
- Earning Date
- XTNT 11-11-2025
- GDL 01-01-0001
- Dividend Yield
- XTNT N/A
- GDL 6.02%
- EPS Growth
- XTNT N/A
- GDL N/A
- EPS
- XTNT N/A
- GDL N/A
- Revenue
- XTNT $127,766,000.00
- GDL N/A
- Revenue This Year
- XTNT $13.03
- GDL N/A
- Revenue Next Year
- XTNT N/A
- GDL N/A
- P/E Ratio
- XTNT N/A
- GDL N/A
- Revenue Growth
- XTNT 15.16
- GDL N/A
- 52 Week Low
- XTNT $0.33
- GDL $7.65
- 52 Week High
- XTNT $0.78
- GDL $8.13
- Technical
- Relative Strength Index (RSI)
- XTNT 56.23
- GDL 55.68
- Support Level
- XTNT $0.62
- GDL $8.51
- Resistance Level
- XTNT $0.67
- GDL $8.59
- Average True Range (ATR)
- XTNT 0.04
- GDL 0.07
- MACD
- XTNT 0.00
- GDL -0.00
- Stochastic Oscillator
- XTNT 75.11
- GDL 78.95
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.